// App-Quantinova.ai

1425 : The Novel Phospholipid Gemcitabine Conjugate KPC34 Has Activity In Acute Leukemia

Researchers

Presenter

  • Timothy S Pardee

Principal Investigators

  • Peter Alexander

  • Kristin Stadelman

  • Greg Kucera

Medical Centers

  • Cancer Biology, Wake Forest University Comprehensive Cancer Center, Winston-Salem, NC

  • Internal Medicine, Section on Hematology and Oncology, Wake Forest Baptist Health, Winston-Salem, NC

  • Comprehensive Cancer Center Wake Forest University, Winston-Salem, NC

  • Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University, Winston-Salem, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Extracellular signal-regulated kinase

Drug/Treatment

  • Decitabine

  • Gemcitabine

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved